There have been 50 recent insider transactions recorded for Galera Therapeutics, Inc. (GRTX), including 40 buys and 3 sells. Total insider buying was valued at $3.86M and total insider selling at $4.83K.
Notable insiders with recent activity include Sorensen Mel, Sussman Joel F., Chang Nancy T. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.
Insider Transactions — GRTX
| Date |
Name |
Role |
Transaction |
Shares |
Avg. Price |
Value |
Shares Owned |
| 2025-05-01 |
Sorensen Mel |
President and CEO |
RSU Award |
6,000,000 |
$0.02 |
$132K |
6,000,000 |
| 2025-05-01 |
Sussman Joel F. |
Chief Accounting Officer |
RSU Award |
2,000,000 |
$0.02 |
$44K |
2,000,000 |
| 2025-02-24 |
Chang Nancy T |
10 Percent Owner |
RSU Award |
96,000 |
$0.04 |
$3.94K |
96,000 |
| 2025-02-24 |
Lokay Kevin G |
Director |
RSU Award |
48,000 |
$0.04 |
$1.97K |
48,000 |
| 2025-02-24 |
Alleva Lawrence M |
Director |
RSU Award |
48,000 |
$0.04 |
$1.97K |
48,000 |
| 2025-02-24 |
Friedman Michael R. |
Director |
RSU Award |
96,000 |
$0.04 |
$3.94K |
96,000 |
| 2024-12-30 |
Chang Nancy T |
Officer |
Unknown |
- |
- |
- |
- |
| 2024-12-30 |
Chang Nancy T |
10 Percent Owner |
RSU Award |
1,842 |
- |
- |
1,842 |
| 2024-12-30 |
Friedman Michael R. |
Officer |
Unknown |
- |
- |
- |
- |
| 2024-12-30 |
Friedman Michael R. |
Director |
RSU Award |
8,326 |
- |
- |
8,326 |
| 2024-08-16 |
Sorensen Mel |
President and CEO |
Informative Sell |
67,015 |
$0.07 |
$4.83K |
265,029 |
| 2024-04-19 |
Schneid Yair |
10 Percent Owner |
Informative Buy |
100 |
$0.19 |
$18.55 |
10,723,710 |
| 2024-04-18 |
Schneid Yair |
10 Percent Owner |
Informative Buy |
17,211 |
$0.19 |
$3.18K |
10,193,221 |
| 2024-04-17 |
Schneid Yair |
10 Percent Owner |
Informative Buy |
100,000 |
$0.19 |
$19.1K |
8,461,353 |
| 2024-04-16 |
Soffer Rochel |
10 Percent Owner |
Unknown |
- |
- |
- |
2,750,000 |
| 2024-02-08 |
Schneid Yair |
10 Percent Owner |
Informative Buy |
150,000 |
$0.17 |
$25.65K |
8,043,203 |
| 2024-02-07 |
Schneid Yair |
10 Percent Owner |
Informative Buy |
25,000 |
$0.17 |
$4.25K |
7,743,203 |
| 2024-02-06 |
Schneid Yair |
10 Percent Owner |
Informative Buy |
25,000 |
$0.20 |
$5.03K |
7,718,203 |
| 2024-02-05 |
Schneid Yair |
10 Percent Owner |
Informative Buy |
97,402 |
$0.18 |
$17.92K |
7,693,203 |
| 2024-01-30 |
Schneid Yair |
10 Percent Owner |
Informative Buy |
335,000 |
$0.18 |
$60.64K |
7,595,801 |
| 2024-01-29 |
Schneid Yair |
10 Percent Owner |
Informative Buy |
150,000 |
$0.18 |
$27K |
7,260,801 |
| 2024-01-05 |
Schneid Yair |
10 Percent Owner |
Disposition |
- |
- |
- |
7,110,801 |
| 2023-12-31 |
Altamont Pharmaceutical Holdings, Llc |
10 Percent Owner |
Unknown |
- |
- |
- |
- |
| 2023-10-31 |
Altamont Pharmaceutical Holdings, Llc |
10 Percent Owner |
Unknown |
- |
- |
- |
5,280,000 |
| 2023-07-01 |
Alleva Lawrence M |
Director |
RSU Award |
22,762 |
$3.12 |
$71.02K |
22,762 |
| 2023-07-01 |
West Linda |
Director |
RSU Award |
23,382 |
$3.12 |
$72.95K |
23,382 |
| 2023-06-14 |
Powell Michael |
Director |
RSU Award |
64,000 |
$3.27 |
$209.28K |
64,000 |
| 2023-06-14 |
Lokay Kevin G |
Director |
RSU Award |
48,000 |
$3.27 |
$156.96K |
48,000 |
| 2023-06-14 |
Alleva Lawrence M |
Director |
RSU Award |
48,000 |
$3.27 |
$156.96K |
48,000 |
| 2023-06-14 |
Cunningham Emmett |
Director |
RSU Award |
48,000 |
$3.27 |
$156.96K |
- |
| 2023-06-14 |
West Linda |
Director |
RSU Award |
48,000 |
$3.27 |
$156.96K |
48,000 |
| 2023-03-16 |
Bachleda Mark |
Chief Commercial Officer |
Informative Buy |
11,000 |
$2.25 |
$24.72K |
11,000 |
| 2023-03-13 |
Degnan Chris |
Chief Financial Officer |
Informative Buy |
10,000 |
$1.96 |
$19.59K |
10,000 |
| 2023-03-10 |
Sorensen Mel |
President and CEO |
Informative Buy |
100,000 |
$1.68 |
$168.12K |
332,044 |
| 2023-02-25 |
Beardsley Robert A |
Chief Operating Officer |
RSU Award |
135,000 |
$1.78 |
$240.3K |
135,000 |
| 2023-02-25 |
Stacey Jennifer Evans |
See Remarks |
RSU Award |
135,000 |
$1.78 |
$240.3K |
135,000 |
| 2023-02-25 |
Sorensen Mel |
President and CEO |
RSU Award |
440,000 |
$1.78 |
$783.2K |
440,000 |
| 2023-02-25 |
Kennedy Eugene P. |
Chief Medical Officer |
RSU Award |
55,000 |
$1.78 |
$97.9K |
55,000 |
| 2023-02-25 |
Degnan Chris |
Chief Financial Officer |
RSU Award |
185,000 |
$1.78 |
$329.3K |
185,000 |
| 2023-02-25 |
Bachleda Mark |
Chief Commercial Officer |
RSU Award |
135,000 |
$1.78 |
$240.3K |
135,000 |
| 2022-11-21 |
Beardsley Robert A |
Chief Operating Officer |
Option Exercise (Sell) |
10,000 |
- |
- |
75,651 |
| 2022-09-01 |
Kennedy Eugene P. |
Officer |
Unknown |
- |
- |
- |
- |
| 2022-09-01 |
Kennedy Eugene P. |
Chief Medical Officer |
RSU Award |
150,000 |
$1.29 |
$193.5K |
150,000 |
| 2022-07-18 |
Alleva Lawrence M |
Director |
Gift (Given) |
4,000 |
- |
- |
2,325 |
| 2022-07-01 |
West Linda |
Director |
RSU Award |
58,496 |
$1.29 |
$75.46K |
58,496 |
| 2022-06-15 |
Powell Michael |
Director |
RSU Award |
20,000 |
$1.48 |
$29.6K |
20,000 |
| 2022-06-15 |
Lokay Kevin G |
Director |
RSU Award |
15,000 |
$1.48 |
$22.2K |
15,000 |
| 2022-06-15 |
Alleva Lawrence M |
Director |
RSU Award |
15,000 |
$1.48 |
$22.2K |
15,000 |
| 2022-06-15 |
Cunningham Emmett |
Director |
RSU Award |
15,000 |
$1.48 |
$22.2K |
- |
| 2022-06-15 |
West Linda |
Director |
RSU Award |
15,000 |
$1.48 |
$22.2K |
15,000 |
■ Informative Buy/Sell — open market transaction (most significant)
■ Uninformative Buy — award, option exercise, conversion
■ Uninformative Sell — tax withholding, award vest sale
■ Neutral — gift, trust, expiry
